| RS2136413727 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136413792 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136413869 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136413887 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136413939 |
VWF
|
Health Risk |
Likely pathogenic |
— |
| RS2136414843 |
ATM
|
Health Risk |
Pathogenic |
— |
| RS2136415648 |
GRIN2B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2136415741 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2136415828 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2136415913 |
GRIN2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2136416046 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS2136416346 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136416601 |
TBX5
|
Health Risk |
Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2136416963 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2136417490 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136417619 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 2, von Willebrand disease type 2 |
| RS2136417904 |
TRPV4
|
Health Risk |
Likely pathogenic |
Metatropic dysplasia, Metatropic dysplasia |
| RS2136418056 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2136418232 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2136418265 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2136418310 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2136418333 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136418339 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136418437 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136420496 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 3 |
| RS2136420816 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136421421 |
TBX5
|
Health Risk |
Pathogenic/Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2136421561 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2136421981 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
ATM-related cancer predisposition, ATM-related cancer predisposition |
| RS2136422828 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136422907 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136423257 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136423623 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136423678 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136423753 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136424529 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136426808 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136428332 |
PUS1
|
Health Risk |
Pathogenic |
— |
| RS2136428856 |
PUS1
|
Health Risk |
Likely pathogenic |
— |
| RS2136430552 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136430770 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136430908 |
TRPV4
|
Health Risk |
Likely pathogenic |
Metatropic dysplasia, Metatropic dysplasia |
| RS2136431608 |
AICDA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS2136432221 |
PUS1
|
Health Risk |
Likely pathogenic |
— |
| RS2136432373 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2136433359 |
AICDA
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS2136434803 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2136440246 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136440279 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136440291 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136440316 |
VWF
|
Health Risk |
Pathogenic/Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 1 |
| RS2136440319 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136444136 |
PUS1
|
Health Risk |
Pathogenic |
— |
| RS2136449605 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136450266 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136450623 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2136451316 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136452719 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136453754 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136454053 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136454246 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136454370 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136455744 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 2, von Willebrand disease type 2 |
| RS2136455808 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136455960 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136456013 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136456030 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136456432 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136459200 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136460393 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136462110 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136463344 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136465036 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136466034 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2136466291 |
TRPV4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS2136468103 |
TRPV4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS2136470202 |
GRIN2B
|
Health Risk |
Pathogenic |
— |
| RS2136470299 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 27 |
| RS2136470302 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2136470472 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2136470486 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 2, von Willebrand disease type 2 |
| RS2136470509 |
GRIN2B
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2136470584 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136472072 |
VWF
|
Health Risk |
Likely pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS2136474280 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2136474390 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 3, von Willebrand disease type 3 |
| RS2136475122 |
TRPV4
|
Health Risk |
Likely pathogenic |
Metatropic dysplasia, Metatropic dysplasia |
| RS2136479365 |
GRIN2B
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 27 |
| RS2136479389 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2136479850 |
GRIN2B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 6 |
| RS2136479935 |
GRIN2B
|
Health Risk |
Likely pathogenic |
— |
| RS2136485750 |
MFAP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2136488957 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS2136490630 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136490774 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136492942 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136493530 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136497216 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136497534 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136497891 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |